IP Verse

Elkington And Fife Llp opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Elkington And Fife Llp

Patent Number:
EP3500241
Title:
Combination Therapy For Copd
Applicant:
CHIESI FARMACEUTICI S.P.A.
Opposition Date:
Jul 4, 2024
Patent Number:
EP4106757
Title:
Methods Involving Neutrophil Elastase Inhibitor Alvelestat For Treating Respiratory Disease Mediated By Alpha-1 Antitrypsin Deficiency
Applicant:
MEREO BIOPHARMA 4 LIMITED
Opposition Date:
May 23, 2024
Patent Number:
EP3340989
Title:
Mdm2 Inhibitors And Combinations Thereof
Applicant:
NOVARTIS AG
Opposition Date:
May 15, 2024
Patent Number:
EP3915555
Title:
Pharmaceutical Composition Comprising Glycopyrrolate
Applicant:
MEXICHEM FLUOR S.A. DE C.V.
Opposition Date:
Mar 28, 2024
Patent Number:
EP2877138
Title:
Dual Cap System For Container-Closures To Maintain Tip Sterility During Shelf Storage
Applicant:
ALLERGAN, INC.
Opposition Date:
Mar 27, 2024
Patent Number:
EP3810201
Title:
Gip/Glp1 Agonist Compositions
Applicant:
ELI LILLY AND COMPANY
Opposition Date:
Mar 6, 2024
Patent Number:
EP4066870
Title:
Breast Pump System
Applicant:
CHIARO TECHNOLOGY LIMITED
Opposition Date:
Feb 23, 2024
Patent Number:
EP3512505
Title:
Vildagliptin Pharmaceutical Compositions
Applicant:
GALENICUM HEALTH S.L.
Opposition Date:
Dec 15, 2023
Patent Number:
EP3752488
Title:
Method For Preparing Tert-Butyl N-((1R,2S,5S)-2-((2-((5-Chloropyridin-2-Yl)Amino)-2-Oxoacetyl)Amino)-5-(Dimethylcarbamoyl)Cyclohexyl)Carbamate
Applicant:
MOEHS IBÉRICA, S.L.
Opposition Date:
Dec 7, 2023
Patent Number:
EP3578175
Title:
Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound
Applicant:
AMGEN INC.
Opposition Date:
Aug 29, 2023

Competitors of Elkington And Fife Llp

AMARIN PHARMACEUTICALS IRELAND LIMITED

SEB S.A.

BISSELL INC.

Want to track Elkington And Fife Llp?

Feel free to send us a message here and we will get back to you